Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 59

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 59
---
 tailored to the type of interaction. These           
 reviews are guided by various internal procedures and supervised by the         
 compliance function. Special attention is given to high-risk operations,        
 including interactions with government officials, public bodies, healthcare     
 professionals and healthcare organizations, where the analysis and              
 management of potential conflicts of interest are prioritized. The review       
 processes are designed to encompass the full scope of Grifols’ market           
 activities.                                                                     
 Audit                                                                           
 The Anti-Corruption Policy and Program are reviewed regularly by the            
 internal audit function, which develops an annual audit plan based on a         
 thorough risk analysis. In addition, external and independent audits are        
 conducted to assess different aspects of Grifols’ Global Anti-Corruption        
 Program.                                                                        
 If a potential case of corruption is detected, the company promptly initiates   
 an internal investigation, with the involvement of external legal advisors.     
 The Global Compliance Review Committee supports the Audit Committee of          
 the Board of Directors in overseeing the Global Anti-Corruption Program.        
 The Board of Directors of Grifols, S.A. holds ultimate responsibility for       
 ensuring compliance with the Anti-Corruption Policy and has delegated           
 these oversight responsibilities to the Audit Committee.                        
 Third-party management                                                          
 Grifols’ Global Anti-Corruption Program includes control mechanisms for         
 third parties with whom the company intends to establish commercial             
 or business relationships. Before initiating a commercial relationship,         
 distributors, consultant, agents, brokers or other individuals or entities that 
 are not part of Grifols and that are engaged or used by Grifols to:             
 (1) market, promote, sell and/or distribute Grifols’ products; and/or           
 (2) provide services that enable or support the marketing, promotion, sale,     
 distribution, reimbursement, registration, pricing and/or import-export         
 of, or regulatory-related work for, Grifols’ products and may involve any       
 interactions with government officials undergo a thorough verification          
 process comprising two phases: a first phase to ensure the legitimacy of        
 the intended commercial relationship, and a second phase of due diligence,      
 which includes an in-depth analysis of the third party, covering their          
 organization, key employees, business practices, and reputation.                
 Contracts signed with third parties include anti-corruption obligations and     
 an annex summarizing Grifols’ Anti-Corruption Policy. Additionally, third       
 parties are required to provide an annual certificate of compliance with the    
 ethical standards outlined in the policy.                                       
 Certain third parties, such as international distributors, are